Urdu Translation of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children
NCT ID: NCT06986720
Last Updated: 2025-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2025-05-12
2025-07-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Urdu translation of revised HiMAT will be executed by using forward backwards translation method. Two bilingual translators fluent in both Urdu and English languages will facilitate the researcher in the translation of the tool. This final translated version will be then tested for validity and reliability on all participants of the study. The psychometric properties of the tool will be assessed including reliability, internal consistency, and item discrimination.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Reliability and Validity Study: Urdu Version of Rivermead Extended Activities of Daily Life
NCT05425186
Translation of Modified Fatigue Impact Scale in Urdu Language
NCT05405517
Reliability and Validity of HHIRS General Quality of Life Questionnaire
NCT05350839
Reliability and Validity of Urdu Version of Ronald Morris Disability Questionnaire in Patients With Low Back Pain
NCT05429931
Urdu Version of Menstrual Attitude Questionnaire: A Reliability and Validity Study
NCT05203107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Forward Translation:
Two independent translators who spoke Urdu as their native language will conduct initial translation into Urdu (U-HiMAT).
2. Synthesis:
In this step both translated versions (U1 \& U2) will be synthesized to obtain a common translated version of U-HiMAT. Full Urdu version of scale will be completed.
3. Backward Translation:
Urdu translated version will be translated back into English by a different team consisting of professional independent bilingual translators.
4. Expert Committee:
Expert committees consisting of pediatric physical therapists and pediatric clinical practitioners will evaluate and review the difference between a translated version and an original draft. They will create a pre final version for field testing.
5. Pre-Final Version Testing:
Pre-final Urdu and English version of scale will be tested on patients. Expert panel will review the findings from this process.
After completion of translation process, psychometric properties of the tool will be analysed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No condition affecting mobility of children
* Able to understand and follow instruction.
* Can speak \& understand language
Exclusion Criteria
* Children with conditions affecting their mobility.
* Children with any history of surgery in the past one year.
* Children with any cardiorespiratory comorbidities.
* Children with muscle strain, ligament sprain or joint laxity in lower extremities.
* Cognition less than 20 on Mini Mental State Examination (MMSE).
* Children with any history of any foot deformity
5 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shazia Muheen, MS
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Riphah International University
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Williams G, Pallant J, Greenwood K. Further development of the High-level Mobility Assessment Tool (HiMAT). Brain Inj. 2010;24(7-8):1027-31. doi: 10.3109/02699052.2010.490517.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/RCR&AHS/24/0729
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.